Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paterson

Showing results (361-370 of 401) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastasesAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acidMiguel Martin, Richard Bell, Hugues Bourgeois, et al.
Thrombosis and Haemostasis|April 5, 2018
Erratum to: Thromboelastometry and platelet function during acclimatisation to high altitudeAlistair S Rocke, Gordon G Paterson, Matthew T Barber, et al.
Thrombosis and Haemostasis|January 6, 2018
Thromboelastometry and Platelet Function during Acclimatization to High AltitudeAlistair S Rocke, Gordon G Paterson, Matthew T Barber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapyAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
JNCI Cancer Spectrum|August 11, 2021
<i>MAF</i> Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical PracticeAlexander H G Paterson, Peter C Lucas, Stewart J Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelM Aapro, P A Abrahamsson, J J Body, et al.
Annals of Surgical Oncology|September 25, 2016
Poor Prognosis After Second Locoregional Recurrences in the CALOR TrialIrene L Wapnir, Shari Gelber, Stewart J Anderson, et al.
Breast Cancer Research and Treatment|May 4, 2022
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)Charles E Geyer, Hanna Bandos, Priya Rastogi, et al.
Breast Cancer Research and Treatment|March 1, 2022
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)Charles E Geyer, Hanna Bandos, Priya Rastogi, et al.
Pageof 41

Showing results (361-370 of 401) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastasesAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acidMiguel Martin, Richard Bell, Hugues Bourgeois, et al.
Thrombosis and Haemostasis|April 5, 2018
Erratum to: Thromboelastometry and platelet function during acclimatisation to high altitudeAlistair S Rocke, Gordon G Paterson, Matthew T Barber, et al.
Thrombosis and Haemostasis|January 6, 2018
Thromboelastometry and Platelet Function during Acclimatization to High AltitudeAlistair S Rocke, Gordon G Paterson, Matthew T Barber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapyAllan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
JNCI Cancer Spectrum|August 11, 2021
<i>MAF</i> Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical PracticeAlexander H G Paterson, Peter C Lucas, Stewart J Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelM Aapro, P A Abrahamsson, J J Body, et al.
Annals of Surgical Oncology|September 25, 2016
Poor Prognosis After Second Locoregional Recurrences in the CALOR TrialIrene L Wapnir, Shari Gelber, Stewart J Anderson, et al.
Breast Cancer Research and Treatment|May 4, 2022
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)Charles E Geyer, Hanna Bandos, Priya Rastogi, et al.
Breast Cancer Research and Treatment|March 1, 2022
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)Charles E Geyer, Hanna Bandos, Priya Rastogi, et al.
Pageof 41